公司資料
Oragenics 股價、新聞與催化劑
- 股票代碼:
- OGEN
- 交易所:
- AMEX
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.54 USD (+0.39%)
收盤價
最後更新: 2026年8月17日
2.75M USD
市值
股價為何變動
As of Aug 17, 2026, OGEN closed up 0.39% at $0.5350. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Oragenics is a biotechnology company focused on infectious disease and central nervous system programs. Its story has long been about using small-cap biotech tools to pursue high-unmet-need therapeutic areas.
所在地與產業分類
Oragenics is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.
商業模式特徵
The company depends on early-stage scientific validation, capital discipline, and the ability to focus its pipeline. Investors watch platform shifts, early data, and financing runway.
生技產業定位
Oragenics occupies a speculative small-cap biotech niche. The stock is driven by whether the company can sharpen its thesis enough to sustain investor confidence.
未來催化劑
- Oragenics is a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live biotech milestone. The market is focused on residual value.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。